Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.16 +0.58%
EPS Growth %: -60.5%
Financial Fact:
Net income (loss): -430K
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -60.5%
Financial Fact:
Net income (loss): -430K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- HP Inc. projects mid-single-digit PC market decline in 2027
- Rubico to shift from semi-annual to quarterly financial reporting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
